In patients with chronic liver disease, the most common adverse reactions (≥ 3%) were pyrexia, abdominal pain, nausea, headache, fatigue, and edema peripheral.
In patients with chronic immune thrombocytopenia, the most common adverse reactions (≥ 10%) were headache, fatigue, contusion, epistaxis, upper respiratory tract infection, arthralgia, gingival bleeding, petechiae and nasopharyngitis.
from FDA,2021.06
Avatrombopag is an innovative drug that has shown significant results in the treatment of thrombocytopenia, but the precautions during its use are equally important.What are the pr···【more】
Article source:Lucius LaosRelease date:2025-02-06Recommended:126
Avatrombopag is a novel thrombopoietin receptor agonist, and its safety and side effects have attracted much attention.Does avatrombopag have side effectsTo explore the possible si···【more】
Article source:Lucius LaosRelease date:2025-02-06Recommended:108
Avatrombopag is a drug used to treat thrombocytopenia, but its side effects are of great concern.Are the side effects of avatrombopag seriousWhether the side effects of avatrombopa···【more】
Article source:Lucius LaosRelease date:2025-02-05Recommended:88
Avatrombopag is a drug used to treat thrombocytopenia, but its use may be accompanied by some side effects.What are the side effects of avatrombopag?Avatrombopag may cause some adv···【more】
Article source:Lucius LaosRelease date:2025-02-05Recommended:82
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: